American Vanguard (NYSE:AVD) Director Steven Macicek Acquires 19,000 Shares of Stock

American Vanguard Corporation (NYSE:AVDGet Free Report) Director Steven Macicek purchased 19,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was bought at an average price of $2.09 per share, with a total value of $39,710.00. Following the transaction, the director owned 99,711 shares of the company’s stock, valued at $208,395.99. This represents a 23.54% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

American Vanguard Trading Down 1.6%

Shares of AVD stock opened at $2.19 on Wednesday. American Vanguard Corporation has a 1 year low of $2.03 and a 1 year high of $5.92. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.47 and a quick ratio of 1.40. The stock’s 50 day simple moving average is $2.60 and its two-hundred day simple moving average is $3.16. The company has a market cap of $64.75 million, a PE ratio of -1.16 and a beta of 1.43.

American Vanguard (NYSE:AVDGet Free Report) last announced its earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.43). The company had revenue of $116.75 million during the quarter, compared to analysts’ expectations of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

Hedge Funds Weigh In On American Vanguard

Institutional investors and hedge funds have recently bought and sold shares of the company. Strs Ohio purchased a new stake in shares of American Vanguard during the 1st quarter valued at $28,000. nVerses Capital LLC purchased a new position in American Vanguard during the 4th quarter worth $42,000. R Squared Ltd acquired a new position in American Vanguard during the 1st quarter valued at about $28,000. Virtu Financial LLC acquired a new position in American Vanguard during the 4th quarter valued at about $52,000. Finally, Jain Global LLC purchased a new stake in American Vanguard in the fourth quarter valued at about $53,000. 79.00% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Wall Street Zen lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a research report on Saturday. Weiss Ratings restated a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Report on American Vanguard

American Vanguard Company Profile

(Get Free Report)

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

Recommended Stories

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.